Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Organisation › Details

NuPharm (Group)

Created in August 2016, following the acquisition by funds advised by Apax Partners, the Group Invent Farma / neuraxpharm is a leader in generic pharmaceutical products for the treatment of disorders of the central nervous system (CNS). The Group is the combination of the Barcelona-based Invent Farma with Düsseldorf-based neuraxpharm. Invent Farma has 50 years’ experience in the development, manufacturing and marketing of pharmaceutical products, while neuraxpharm is a leading CNS brand that has earned the trust of specialist doctors, pharmacists and patients in over three decades. The Group markets, through Qualigen and neuraxpharm, generics drugs from a combined portfolio of predominantly differentiated products mainly in the CNS field. In addition, the Group owns and operates two manufacturing plants in Spain: one of the plants to produce hard-to-make active pharmaceutical ingredients (APIs) with a unique expertise in the respiratory area (Inke), and the other one to produce finished dosage forms (FDFs) across multiple therapeutic areas (Lesvi). *

 

Period Start 2016-08-01 reorganised
  Predecessor Invent Farma/Neuraxpharm (Group)
Products Industry CNS drug (neurological drug)
  Industry 2 DRUGS, GENERICS
Person Person Walz, Stephan (Invent Pharma / Neuraxpharm 201706 CEO)
     
Region Region Barcelona
  Country Spain (España)
  City n. a. 
    Address record changed: 2018-07-09
     
Basic data Employees n. a.
     
    * Document for »About Section«: Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf.
     
   
Record changed: 2023-07-10

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for NuPharm (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px




» top